Table 2 Presence of HPV DNA in histological positive and negative peri-tumor tissues and lymph nodes from cervical cancer patients

SCC-04

SCC

3

IB

3/6 (50)

0/4 -

4/6 (66.6)

2/4 (50)

HPV16

Pelvic

SCC-05

SCC

2

IA

0/2 -

0/1 -

0/2 -

0/1 -

HPV18

No

SCC-07

SCC

3

IIIB

1/2 (50)

0 -

1/2 (50)

0 -

HPV35

Lung

SCC-09

SCC

3

IA

0/4 -

0/1 -

0/4 -

0/1 -

n/a

No

SCC-12

SCC

2

IIA

0 -

0/1 -

0 -

0/1 -

HPV16

Pelvic/Lung

SCC-20

SCC

3

IA

0/3 -

0/2 -

0/3 -

0/2 -

n/a

No

SCC-22

SCC

2

IB

0/2 -

0/3 -

1/2 (50)

2/3 (66.6)

HPV45

No

SCC-24

SCC

1

IB

0/2 -

0/6 -

1/2 (50)

5/6 (83.3)

HPV16

n/a

SCC-39

SCC

3

IIB

0 -

1/4 (25)

0 -

3/4 (75)

HPV16

Lung

SCC-41

SCC

3

IB

0/3 -

2/3 (66.6)

1/3 (33.3)

0/3 -

HPV66

No

SCC-42

SCC

2

IA

0 -

0/3 -

0 -

0/3 -

n/a

No

SCC-43

SCC

3

IB

0 -

0/9 -

0 -

0/9 -

n/a

No

SCC-44

SCC

3

IB

8/9 (88.8)

0/6 -

8/9 (88.8)

6/6 (100)

HPV16

n/a

SCC-45

SCC

1

IB

11/11 (100)

1/10 (10)

11/11 (100)

1/10 (10)

HPV16

n/a

SCC-46

SCC

3

IB

0 -

0/8 -

0 -

0/8 -

HPV16

n/a

SCC-47

SCC

3

IIB

0 -

0/2 -

0 -

0/2 -

HPV16

Dead

AC-10

AC

3

IB

0/5 -

0/3 -

1/5 (20)

0/3 -

HPV16

n/a

AC-11

AC

2

IIA

0/1 -

1/4 (25)

0/1 -

1/4 (25)

HPV18

n/a

AC-18

AC

3

IB

0/4 -

0/2 -

0/4 -

0/2 -

n/a

No

AC-19

AC

2

IIA

0 -

0/1 -

0 -

0/1 -

HPV18

Pelvic